Shaanxi Kanghui Pharm Co Ltd Total Liabilities
Shaanxi Kanghui Pharm Co Ltd total liabilities. Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has total liabilities worth CN¥1.12 Billion CNY (≈ $164.48 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shaanxi Kanghui Pharm Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shaanxi Kanghui Pharm Co Ltd (2012–2025)
Total liabilities of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025. This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Shaanxi Kanghui Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shandong Donghong Pipe Ind Co
SHG:603856
|
China | CN¥929.28 Million |
|
Shanghai Welltech Automation Co Ltd
SHE:002058
|
China | CN¥942.71 Million |
|
Caleres Inc
NYSE:CAL
|
USA | $1.40 Billion |
|
Quanta Storage
TWO:6188
|
Taiwan | NT$6.21 Billion |
|
Nanjing Zhongbei Group Co Ltd
SHE:000421
|
China | CN¥4.88 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$7.49 Billion |
|
Epigral Ltd.
NSE:EPIGRAL
|
India | Rs-22.21 Billion |
|
Guangzhou Hangxin Aviation Technology Co Ltd
SHE:300424
|
China | CN¥1.76 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Shaanxi Kanghui Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603139 total assets.
Liquidity & Leverage Metrics
Shaanxi Kanghui Pharm Co Ltd Total Liabilities Ratios Explained
Shaanxi Kanghui Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shaanxi Kanghui Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shaanxi Kanghui Pharm Co Ltd (2012–2025)
The table below shows the annual total liabilities of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.25 Billion ≈ $182.25 Million |
+26.96% |
| 2024-12-31 | CN¥980.94 Million ≈ $143.54 Million |
-4.93% |
| 2023-12-31 | CN¥1.03 Billion ≈ $150.99 Million |
+29.66% |
| 2022-12-31 | CN¥795.75 Million ≈ $116.44 Million |
+6.78% |
| 2021-12-31 | CN¥745.20 Million ≈ $109.05 Million |
+212.75% |
| 2020-12-31 | CN¥238.27 Million ≈ $34.87 Million |
+109.28% |
| 2019-12-31 | CN¥113.85 Million ≈ $16.66 Million |
-13.01% |
| 2018-12-31 | CN¥130.88 Million ≈ $19.15 Million |
+9.34% |
| 2017-12-31 | CN¥119.70 Million ≈ $17.52 Million |
-9.43% |
| 2016-12-31 | CN¥132.16 Million ≈ $19.34 Million |
+9.38% |
| 2015-12-31 | CN¥120.82 Million ≈ $17.68 Million |
+7.61% |
| 2014-12-31 | CN¥112.27 Million ≈ $16.43 Million |
-4.34% |
| 2013-12-31 | CN¥117.37 Million ≈ $17.17 Million |
+11.44% |
| 2012-12-31 | CN¥105.31 Million ≈ $15.41 Million |
-- |
About Shaanxi Kanghui Pharm Co Ltd
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biolo… Read more